Management of Vasovagal Syncope

Initial Management Approach

The European Society of Cardiology recommends patient education and reassurance about the benign nature of vasovagal syncope as the cornerstone of treatment for most patients 1, 2
Recognition of premonitory symptoms is crucial to help patients identify an impending episode and take preventive measures 1
Avoidance of trigger factors such as hot, crowded environments, volume depletion, prolonged standing, emotional upset or painful stimuli, and venipuncture (when possible) is recommended 1, 2, 3

Increased dietary salt and fluid intake (2-2.5 liters per day) is among the safest initial approaches for volume expansion 1, 4
Sport drinks and salt tablets can be used as volume expanders 2
Head-up tilt sleeping (>10°) may help with posture-related syncope 4, 5
Leg crossing with muscle tensing, squatting, and isometric arm tensing or handgrip during prodromal symptoms can help prevent syncope 6, 5, 3
Compression garments or abdominal binders can reduce venous pooling 5, 3
Tilt-training (progressively prolonged periods of enforced upright posture) can be effective in highly motivated patients 1, 4
Moderate exercise training, especially swimming, can help manage vasovagal syncope 4, 3

Beta-blockers are NOT recommended as first-line therapy as evidence fails to support their efficacy 1, 4
Fludrocortisone (0.1-0.2 mg daily) may be considered in patients who don't respond to non-pharmacological measures 4, 5
Midodrine (an alpha-agonist) has shown some benefit in controlled studies but is generally considered after non-pharmacological approaches 5, 3

Treatment is not necessary for patients who have experienced only a single syncope episode and are not in a high-risk setting 4
Patients in high-risk settings (e.g., commercial vehicle drivers, pilots, machine operators) may require more aggressive treatment approaches 4
Cardiac pacing should be reserved for specific cases with documented cardioinhibitory response, age >40, and frequent unpredictable syncope after alternative therapies have failed 5

Overtreatment of patients with infrequent episodes should be avoided 4
Failure to discontinue or modify hypotensive medications that may be contributing to symptoms should be addressed 1
Ignoring supine/nocturnal hypertension when using volume expansion strategies should be avoided 4